Profile data is unavailable for this security.
About the company
GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
- Revenue in USD (TTM)20.63bn
- Net income in USD2.09bn
- Incorporated2022
- Employees54.00k
- LocationGE Healthcare Technologies Inc500 West Monroe StreetCHICAGO 60661United StatesUSA
- Phone+1 (203) 360-4369
- Fax+1 (302) 655-5049
- Websitehttps://www.gehealthcare.com
More ▼
Mergers & acquisitions
| Acquired company | GEHC:NSQ since announced | Transaction value |
|---|---|---|
| Intelerad Medical Systems Inc | 8.05% | 2.30bn |
| Icometrix NV | -0.74% | -- |
Data delayed at least 15 minutes, as of Mar 03 2026 21:00 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zimmer Biomet Holdings Inc | 8.23bn | 704.60m | 19.47bn | 17.00k | 28.06 | 1.53 | 10.82 | 2.36 | 3.55 | 3.55 | 41.44 | 64.95 | 0.3703 | 1.10 | 5.17 | 484,211.80 | 3.17 | 3.03 | 3.58 | 3.46 | 69.71 | 71.01 | 8.56 | 9.10 | 1.10 | 4.71 | 0.3718 | 29.26 | 7.20 | 6.08 | -21.98 | -- | 9.26 | 0.00 |
| Illumina Inc | 4.34bn | 850.00m | 20.32bn | 8.60k | 24.26 | 7.47 | 18.14 | 4.68 | 5.48 | 5.48 | 27.88 | 17.80 | 0.6709 | 2.61 | 5.34 | 505,000.00 | 13.13 | -10.15 | 17.32 | -12.15 | 66.61 | 65.39 | 19.57 | -23.18 | 1.72 | 15.79 | 0.4221 | -- | -0.6633 | 6.04 | 169.50 | 5.32 | -4.77 | -- |
| Steris PLC | 5.83bn | 708.66m | 24.30bn | 17.79k | 34.48 | 3.40 | 20.30 | 4.17 | 7.19 | 7.18 | 59.09 | 72.93 | 0.5658 | 4.92 | 6.12 | 327,662.40 | 6.91 | 5.04 | 7.59 | 5.51 | 44.11 | 43.75 | 12.21 | 10.69 | 1.75 | 20.99 | 0.2094 | 37.51 | 6.24 | 12.49 | 10.64 | 8.40 | 11.52 | 8.99 |
| DexCom Inc | 4.66bn | 836.30m | 28.40bn | 11.00k | 35.71 | 10.34 | 26.10 | 6.09 | 2.07 | 2.07 | 11.50 | 7.14 | 0.727 | 3.02 | 4.20 | 423,818.20 | 13.04 | 8.85 | 21.58 | 12.58 | 62.09 | 63.92 | 17.94 | 14.21 | 1.59 | -- | 0.3204 | -- | 15.60 | 19.33 | 45.14 | 8.75 | 12.81 | -- |
| Veeva Systems Inc | 3.08bn | 860.33m | 29.83bn | 7.29k | 35.29 | 4.24 | 33.14 | 9.68 | 5.14 | 5.14 | 18.41 | 42.84 | 0.4234 | -- | 9.15 | 422,472.40 | 11.83 | 11.33 | 13.50 | 14.35 | 75.67 | 72.60 | 27.93 | 23.96 | -- | -- | 0.00 | 0.00 | 16.20 | 19.99 | 35.84 | 18.85 | 36.56 | -- |
| Waters Corp | 3.17bn | 642.63m | 30.14bn | 7.90k | 28.56 | 7.14 | 35.47 | 9.52 | 10.76 | 10.76 | 53.01 | 43.01 | 0.6574 | 2.46 | 4.05 | 400,669.10 | 13.35 | 17.03 | 16.91 | 21.51 | 59.28 | 59.00 | 20.30 | 22.40 | 1.27 | 15.81 | 0.3546 | 0.00 | 6.99 | 6.00 | 0.7518 | 4.26 | -8.14 | -- |
| Agilent Technologies Inc | 7.07bn | 1.29bn | 33.41bn | 18.10k | 26.09 | 4.84 | 21.24 | 4.73 | 4.53 | 4.53 | 24.81 | 24.44 | 0.5714 | 3.26 | 4.96 | 390,331.50 | 10.43 | 11.44 | 12.51 | 13.67 | 52.53 | 53.25 | 18.26 | 18.82 | 1.59 | 19.12 | 0.3268 | 20.76 | 6.73 | 5.41 | 1.09 | 12.63 | 27.88 | 7.10 |
| GE HealthCare Technologies Inc | 20.63bn | 2.09bn | 36.53bn | 54.00k | 17.61 | 3.52 | 13.37 | 1.77 | 4.55 | 4.55 | 45.03 | 22.77 | 0.5893 | 5.93 | 4.31 | 381,944.40 | 6.15 | 6.70 | 8.46 | 9.25 | 39.98 | 40.44 | 10.44 | 10.49 | 1.13 | 9.97 | 0.4866 | 1.85 | 4.84 | 3.74 | 4.57 | 0.7558 | 13.23 | -- |
| Resmed Inc | 5.40bn | 1.49bn | 37.50bn | 10.60k | 25.44 | 5.93 | 22.18 | 6.95 | 10.12 | 10.12 | 36.75 | 43.39 | 0.6901 | 2.34 | 5.53 | 509,256.50 | 19.00 | 15.33 | 21.94 | 17.76 | 60.85 | 57.29 | 27.53 | 21.96 | 2.32 | -- | 0.095 | 28.94 | 9.84 | 11.72 | 37.20 | 17.64 | -1.02 | 1.69 |
| Becton Dickinson and Co | 21.92bn | 1.76bn | 50.27bn | 72.00k | 28.86 | 1.99 | 11.90 | 2.29 | 6.12 | 6.12 | 76.34 | 88.79 | 0.4004 | 2.96 | 8.52 | 304,500.00 | 3.21 | 3.00 | 3.78 | 3.48 | 46.42 | 45.58 | 8.01 | 8.20 | 0.5826 | 6.68 | 0.4359 | 66.89 | 8.24 | 6.32 | -1.58 | 46.93 | -0.2352 | 5.65 |
| Edwards Lifesciences Corp | 6.07bn | 1.06bn | 50.63bn | 16.00k | 48.26 | 4.90 | 41.76 | 8.35 | 1.81 | 1.83 | 10.36 | 17.80 | 0.4536 | 1.21 | 9.57 | 379,225.00 | 7.89 | 13.08 | 9.04 | 14.96 | 78.01 | 79.39 | 17.40 | 24.79 | 3.09 | -- | 0.0547 | 0.00 | 11.55 | 6.70 | -24.33 | 5.18 | -8.57 | -- |
| IDEXX Laboratories Inc | 4.30bn | 1.06bn | 50.70bn | 11.00k | 48.68 | 31.61 | 42.08 | 11.78 | 13.08 | 13.08 | 53.12 | 20.14 | 1.30 | 4.33 | 7.40 | 391,245.60 | 31.89 | 28.96 | 47.86 | 43.58 | 61.80 | 60.30 | 24.62 | 22.86 | 0.9019 | 37.97 | 0.3456 | 0.00 | 10.42 | 9.72 | 19.33 | 12.74 | 5.08 | -- |
Data as of Mar 03 2026. Currency figures normalised to GE Healthcare Technologies Inc's reporting currency: US Dollar USD
43.94%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2025 | 47.80m | 10.49% |
| Dodge & Coxas of 31 Dec 2025 | 31.21m | 6.85% |
| Capital Research & Management Co. (Global Investors)as of 31 Dec 2025 | 25.36m | 5.57% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 24.94m | 5.48% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 20.05m | 4.40% |
| Harris Associates LPas of 31 Dec 2025 | 15.85m | 3.48% |
| Geode Capital Management LLCas of 31 Dec 2025 | 12.11m | 2.66% |
| Hotchkis & Wiley Capital Management LLCas of 31 Dec 2025 | 9.03m | 1.98% |
| Norges Bank Investment Managementas of 31 Dec 2025 | 7.27m | 1.60% |
| Barrow, Hanley, Mewhinney & Strauss LLCas of 31 Dec 2025 | 6.51m | 1.43% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
